I ask unanimous consent that the order for the quorum call be rescinded. Mr. President, I am going to offer an amendment in a few moments. First, I would like to spend a couple minutes talking about…
I ask unanimous consent that the order for the quorum call be rescinded.
Mr. President, I am going to offer an amendment in a few moments. First, I would like to spend a couple minutes talking about the amendment that was offered by Senator Vitter. I have a copy of the amendment. The amendment deals with the issue of drug reimportation. It says:
None of the funds appropriated in this Act may be used to
prevent an individual not in the business of importing a
prescription drug from importing a prescription drug from
Canada that complies with sections 501, 502, and 505 of the
FDA Cosmetic Act.
I don't have any particular problem with this amendment. It says that the FDA can't do what it is not doing. So that is largely irrelevant to me. It has an appearance of doing something, but it doesn't do anything. At the moment, if you are in Grafton, ND, and you go across the border to Winnipeg, Canada, and buy prescription drugs and bring them across, if you bring across a 90-day supply of prescription drugs for yourself, you are not going to have a problem. They allow a personal reimportation of prescription drugs because very few Americans have the opportunity to drive to Canada to access that. The one area where the Vitter amendment would allow reimportation where there needs to be some safety attached is with respect to Internet sites. But the fact is, those who are now accessing certain Internet sites are doing so, and the FDA is not intervening because they don't have the capability to intervene.
We do have a piece of legislation that is bipartisan. Senator Snowe, Senator Kennedy, Senator McCain, Senator Grassley and myself, many of us, helped write the legislation that would allow the reimportation of prescription drugs on a much broader basis, in a manner that is determined to be safe, where we would actually require Internet sites to be registered and inspected. But let me talk about that in just a moment.
Mr. President, I have kept in my desk here in the Senate something I want to show by consent. These are a couple of bottles of Lipitor. Lipitor is, I think, the most common and perhaps the most popular cholesterol-lowering drug. These two bottles contain 20-milligram tablets of Lipitor. As you can see, the bottles of Lipitor are identical, with the exception of the color--one is blue and one is red on the label. Both of these bottles of Lipitor tablets were made in Ireland. They put some in this bottle, they put some in this bottle, and then they start sending them around. They sent this bottle to the United States, and they sent this bottle to Canada.
Now, understand this: This is an FDA-approved drug, produced in an FDA-approved plant in Ireland, sent to our country, sent to Canada--the same pill, put in the same bottle, made in the same place, FDA- approved. Difference? Well, one has a red label, one has a blue label. And there is another very big difference: one costs twice as much. There is a 96-percent higher price on the one the Americans get to purchase. Difference? Well, no difference in the pill, no difference in the bottle; it is just the American consumer gets to pay twice as much. Now, why is that the case? Well, I could hold up a dozen bottles of medicine and describe many popular brand names and tell you exactly the same thing.
In fact, I will tell you a story. Sitting on a bale of straw once at the farmstead in central North Dakota on a Sunday afternoon, visiting with a group of people, was an 82-, 84-year-old farmer. I was in the farmyard visiting with some farmers at an afternoon stop, and this old codger, a wonderful old guy, said: ``One of the problems me and the Mrs. have had--yes, that is what he said--``One of the problems me and the Mrs. have had is being able to afford prescription drugs. My wife has been fighting breast cancer for a long time. For the last 3 or 4 years, she has been fighting breast cancer. And do you know what? Every 3 months we have had to drive to Canada to buy Tamoxifen to fight her breast cancer. Why do we do that? Because we save 80 percent on the cost, and that is the only way we can afford to buy the medicine, the Tamoxifen for my wife to fight her breast cancer.''
Isn't that something? This guy sitting on a bale of straw, talking to me about what he has to do every 3 months to be able to afford the medicine his wife needs to fight breast cancer.
Now, that is Tamoxifen. We pay, in some cases, 2 times more or 3 times more for the same medicine, so we then have a woman fighting cancer and then fighting the issue of having to pay 2 or 3 times as much for the medicine.
Now, first of all, this is unfair. There is no circumstance under which we ought to ask the American people to pay the highest drug prices in the world for FDA-approved drugs. It is not fair, and it should not happen.
Now, how does it happen that they can enforce this, the pharmaceutical industry can enforce this? Well, they have a law that says the only ability to import drugs into this country is by the pharmaceutical manufacturer itself, the company itself. They are the ones who are able to import. Now, I just mention to you that as a matter of practice, they allow a personal supply of drugs to come across the border for about 90 days' worth of drugs. They do that. But, otherwise, if you are a licensed pharmacist or a wholesaler and you buy an FDA-approved drug, you cannot bring it into this country.
By contrast, let me just describe this: 40 percent of the active ingredients in prescription drugs in this country come from China and India. Forty percent of the active ingredients in our prescription drugs come from China and India.
Let me tell you another statistic that I think is interesting. In this country, we had 1,200-plus inspections of pharmaceutical plants that are producing medicines for the American people--1,200 inspections. Forty percent of the active ingredients for our prescription drugs comes from China
and India, and we have had, in 2006, 16 inspections in China and 62 inspections in India--1,222 inspections in the United States. Isn't that interesting?
I tell you all that as a bit of history just to say this issue of prescription drugs is not new. A bipartisan group of us has worked for a long while on this issue, and we are going to win this issue. It has taken us longer than we had hoped, but we are going to win this issue because it is not fair for the American people to be charged the highest prices in the world for prescription drugs.
We have so far not been able to prevail, not because someone comes to the floor of the Senate and thumbs their suspender and tugs in their trousers and puffs out like a puff adder and says: I stand up here for the pharmaceutical industry; the American people ought to be charged the highest price in the world. Nobody has ever done that. There are other ways to try to derail legislation like this. But, ultimately, I think we will win. We have a wide bipartisan group of Senators who believe we must fix this. Now, how do we fix it? We fix it in a way that allows the reimportation of prescription drugs only from FDA- approved plants, only in circumstances where we apply pedigrees and lot numbers so you can track it back. For example, you could not import from an Internet site unless that Internet site had been inspected and certified to make sure this is a safe source from which to order prescription drugs.
We have a piece of legislation we believe--and almost everyone who has testified in hearings believes--solves all of those problems, including dramatically increasing the security of all the other issues that are now being complained about with respect to counterfeit drugs. How does it happen we have counterfeit drugs? Well, it happens because we do not have enough inspections. We do not have enough attention to these things. We do not have a pedigree requirement. There are a number of things our legislation would require. But at that point, we would allow the American people to have access to this market and be able to shop for an FDA-approved drug from a country in which they pay one- half, one-fourth, and in some cases one-tenth the price the American consumer is charged.
So let me say, I do not object to the Vitter amendment. I would hope they would just take it. It has been offered to other issues. I would just say, however, that it really does not do much because it is saying to the agency: Don't do what you are not doing. I do not have objection to that. But I do want to say this: There is a serious approach with respect to prescription drug issues that we need to get about the business of dealing with, and we are trying very hard to get it to the floor and get it passed. We will get that done at some point soon, in my judgment.
Having said that, I would like to offer an amendment to the underlying bill. Before I do, I think this is not only an obligation but an opportunity for me to say to Senator Harkin and Senator Specter and others who have worked on the legislation that I think they have done an awfully good job in putting together legislation that invests in people's lives and invests in the health of this country, and I appreciate their work a lot. So I just want to say thanks. This is a big piece of legislation. It is hard to put together. It is not an easy job to carry this to the floor of the Senate, so thanks for what they have done.
Amendment No. 3335 to Amendment No. 3325
Mr. President, if there is an amendment pending, I ask unanimous consent that the pending amendment be set aside so I might send an amendment to the desk.
Mr. President, I ask unanimous consent that reading of the amendment be dispensed with.
Mr. President, this issue is not a large issue in the context of the bill that has been brought to the floor of the Senate-- it deals with $5 million of resources--but I want to talk just for a few moments about it. It deals with the issue of heart disease and stroke.
There is no one in this Chamber, I expect, who has not been affected by heart disease in dramatic ways. I lost a beautiful young daughter to heart surgery, and I think of her every day. I have dedicated a lot of my time and interest in working with the American Heart Association and many others to find the resources to continue to invest in the research and unlock the mysteries of this terrible disease.
It is estimated that about 80 million American adults--1 in 3 males and females--suffer from heart disease. It is estimated that an American dies from cardiovascular disease every 35 seconds in this country. It has a very steep price tag. I know it. My family knows it. Perhaps, I would guess, every Member of the Senate knows it from having lost a friend, an acquaintance, a family member. The medical expenses attributable to heart disease in this country are about $430 billion a year, including lost productivity. But the good news is that this is one of those diseases where we have made substantial progress. In the past 50 years, the fight against heart disease and stroke has been pretty remarkable.
I recall Senator Harkin, and myself, and Senator Specter--I think there were five or six or seven of us who decided we were going to double the investment in the National Institutes of Health. As I recall, about then we were funding it at around $12 billion a year. A group of us decided: What better investment in this country's future than to decide to double the amount of money at the National Institutes of Health to research and to discover opportunities to cure these terrible diseases and treat these awful diseases. I am so proud of what has been done. It is pretty remarkable.
I heard this morning at a hearing over in the Commerce Committee something I have heard so often that I am so sick and tired of. One of our colleagues said there is nothing the Federal Government does that is really worth anything, nothing the Federal Government manages that ever works out.
Well, let me tell you something. Dr. Francis Collins is one of the significant people who engaged in something that, by the way, came from earmarked funding, started here in the U.S. Congress, right here in the U.S. Senate, the Human Genome Project. Do you know that? As a result of the Human Genome Project, we now have unlocked the mysteries of the genetic code. We now, for the first time, have an owner's manual for the human body. Do you know what that means? Well, not a lot of people understand it every day, but every single day, scientists and researchers are understanding those genetic codes and making giant strides in beginning to find cures for diseases.
Dr. Francis Collins came back from Cambridge, England, about, oh, maybe 2 months ago, and I saw him at Dulles Airport when he landed. He had gone for a conference in England about how the researchers were using the genetic information from the Human Genome Project. He said: I thought it was going to take much, much longer. What is going on now is breathtaking in using the Human Genome Project to find the opportunity to treat and to cure some of these diseases. He said it is breathtaking.
That is the Federal Government. This is a civil servant, by the way. As to the research that is going on at NIH, these are people on the Federal payroll. So to my colleagues who think nothing works, let me just tell you something: There is only one place on Earth where the Human Genome Project reached success. And, yes, it was a collaboration, but we did it. It is going to improve lives, and it is going to unlock
the mysteries of terrible diseases. It was a good thing to do.
But my point is, Senator Harkin and Senator Specter were two--and I think Senator Feinstein--and I was one who decided we were going to double the research funding at the National Institutes of Health. Guess what that has done for this country. It allows me to stand here and say we are making great progress on heart disease. We really are. The survival rates for cancer are up. So we are making progress.
The reason I wanted to offer this amendment is this amendment deals with heart disease and stroke. We know the risk factors for heart disease and stroke. We know if you understand the risk factors, you can substantially reduce the risk of heart disease and stroke--by not smoking, by maintaining a healthy weight, and avoiding diabetes, high blood pressure, high cholesterol. We know you can do that. In fact, by taking these steps, individuals often can add 10 years to their lives. So we have made some progress by making investments. There is a long way to go. We have 105 million Americans who have high cholesterol and 72 million Americans have high blood pressure, so we have to do a much better job of educating the public about cardiovascular disease. That is the goal of what is called the State Heart Disease and Stroke Prevention Program at CDC.
What I have offered, very simply, as I close, is a $5 million addition to the State Heart Disease and Stroke Prevention Program at CDC. It is a program that works. We know it works. It needs this additional funding to make it more widely available. This initiative will help States create the programs, the private-public sector partnerships, that will help individuals in controlling blood pressure, lowering cholesterol, and learning the signs and symptoms of heart disease and stroke.
This is a program that we know works. I am hoping that finding an offset, which I have suggested in my amendment, would allow us to accept the amendment. I did not intend to take quite this length of time, but I needed only to say to Senator Harkin and Senator Specter how much I appreciate their work, and my hope is that having highly complimented them, they will be motivated to accept this amendment. I compliment them even if they do not accept it, but I have high hopes.
Mr. President, I ask unanimous consent that the order for the quorum call be rescinded.
Mr. President, I ask unanimous consent that the pending amendment be set aside.
Mr. President, I send an amendment to the desk and ask for its immediate consideration.
Mr. President, I ask unanimous consent that the reading of the amendment be dispensed with.
Mr. President, I offer this amendment on behalf of myself, Senator Brown, Senator Stabenow, and Senator Casey.
Mr. President, this amendment calls for a study and a report, and I want to describe the purpose of it and why I am offering it today. It requires the Department of Labor to determine in a study and report to the Congress the number of jobs lost to the North American Free Trade Agreement and the number of jobs created due to the North American Free Trade Agreement.
Now, it is interesting. In an October 4 Wall Street Journal article, there was a story, front page, with the headline ``Republicans Grow Skeptical of Free Trade.'' Republicans grow skeptical of free trade. Actually, the story described skepticism by everybody about what is called free trade, but it was talking about the politics of it, and so the story described a poll which found that by a 2-to-1 margin Republican voters believed free trade deals have been bad for this country's economy. It turns out that the dissatisfaction with the current trade strategy is bipartisan, not just Republican.
The poll found that 59 percent of polled Republican voters agreed with this statement: Foreign trade has been bad for the U.S. economy because imports from abroad have reduced demand for American-made goods and it has cost jobs here at home and produced potentially unsafe products.
The poll also describes that all voters essentially feel this way; it is not just Republican voters. But as I indicated, it was trying to take a political look at an issue that is very important.
We are going to have a number of free trade agreements come to the floor of the Senate soon. We will have one from Peru, Colombia, Panama, and South Korea. It is interesting that the Wall Street Journal describes how the American people feel about these trade agreements. I think it is not the case that people feel trade is not important. I believe in trade, and plenty of it. I just insist that trade be fair.
I want to go back with this amendment to the North American Free Trade Agreement because that free trade agreement dates back almost-- well, it is over a decade now, and we have had substantial experience with it. Those who negotiated it--and, incidentally, it was negotiated beginning under the first President Bush, concluding under President Clinton. He sent it to this Senate, and I, at that point, was one of the leaders waging a fight against it. But when it was debated in Congress, it was alleged by economists and virtually everybody that it would result in the creation of 200,000 new jobs for our country. If we would pass this new trade agreement, 200,000 jobs would be created in our country.
Well, what has happened with the trade agreement? Let me describe what has happened, and I will describe it in a way that the administration and the Commerce Department and Labor Department would describe it. They would say what an unbelievable success this trade agreement has been. How on Earth would you be critical of a trade agreement that has increased our exports from the United States to Mexico? It has increased our exports to Mexico. And it has. It sure has. But it has increased our imports from Mexico much, much, much more. What started prior to the North American Free Trade Agreement as a $1.5 billion surplus with Mexico--a trade surplus with Mexico--has now become nearly a $60 billion, close to $70 billion trade deficit. So it's a trade surplus converted to a big trade deficit.
Now, I didn't take a lot of higher math, but I understand if you turn a trade surplus into a big trade deficit, that is not a positive outcome for your country. That is a negative approach, and it means lost jobs. It means you are going to have to repay that trade debt with a lower standard of living someday.
In fact, the proponents of NAFTA some years ago relied on a study by Gary Clyde Hufbauer and Jeffrey Schott. It was called the Hufbauer/ Schott, and it was the one cited by everybody. They actually said it is going to create 170,000 new jobs in our country--net new jobs. That was rounded up by the proponents to 200,000. That was going to be nirvana. We would pass this trade agreement and get 200,000 net new jobs. That was how it would work. Except that we passed it and we went from a $1.5 billion trade surplus with Mexico to a nearly $70 billion trade deficit. Now, that is headed in the wrong direction, and that means lost jobs.
I took a look at this, and I asked some while ago, 10 years after NAFTA had been approved, to commission a study from the Congressional Research Service to identify the top 100 American companies that had laid off U.S. workers as a result of NAFTA between 1994 and 2002, and here is the list of the top 100 companies. The list totals about 412,000 U.S. jobs that have been certified as lost. Now, this is not some speculation. This is a program at the Department of Labor that a company has to actually certify to in order to get some help for their employees--trade adjustment assistance. They certify that because of NAFTA these jobs are gone.
The Congressional Research Service turned to the Department of Labor, which has this program, and they said: Can you give us this information? They gave us the information. This means we can directly attribute these job losses to NAFTA, because that is the certification. Of the roughly 412,000 jobs that have been certified, actually of the top 100 companies, 201,000 jobs are attributable to these 100 names.
But if you look at the companies, it is very interesting. Levi Strauss is No. 2. Levi Strauss. I mean, you know, slip on a pair of Levis. Anything more all American than putting on a pair of Levis? There is not one pair of Levis made in the United States of America, not one. We passed NAFTA and Levis go south. We still wear them, all right. They are just shipped north so we can slip them on. So Levi Strauss: 15,676 people, some were proud, I bet, going to work in the morning to make a pair of Levis. But no more. I understand there is not one pair of Levis made in America.
Kraft Foods. Kraft Foods is on the list. Kraft Foods decided they were going to shut down their cookie plant in Fair Lawn, NJ. They made Fig Newton cookies. So they moved Fig Newton cookies to Monterrey, Mexico, and 955 jobs were certified as lost. Fig Newton. Now, I don't know whether there is some inherent capability in Mexico to shovel fig paste in a more expeditious manner than exists in New Jersey. I doubt it. My guess is, just as Levi went south in search of cheap labor, so too did Fig Newton cookies.
So the next time somebody says let's go out and buy some Mexican food, buy Fig Newton cookies. They left New Jersey and ended up in Monterrey, Mexico. Mexican food.
What about Fruit of the Loom underwear? We all understand it; some wear it. Fruit of the Loom underwear--5,352 workers in Texas were certified and thousands more in Louisiana were certified to the Labor Department as having lost their jobs due to NAFTA. Actually, when that happened it was pretty big news around the country, because Fruit of the Loom laid off a lot of people, and I came to the floor and said: It is one thing to lose your shirt--and then I stopped, because I realized we shouldn't joke about jobs lost with Fruit of the Loom.
But these were people who made underwear--probably, I am sure, very proud of their jobs. They probably worked for a career. Is there no market for underwear any more? People stopped wearing them? I don't think so. The underwear is made, it is just not made in America. Fruit of the Loom is gone, and it was certified to have gone and the jobs are lost.
Mattel's western Kentucky plant, making Barbie playhouses and battery-powered pickup trucks for nearly 30 years, 980 employees went from a job in Kentucky to being unemployed. The plant went to Mexico to produce Mattel toys.
John Deere, 1150 employees, lawn mowers and chain saws, jobs gone to Mexico.
Well, all of these are just numbers. You know, you could pick any one of them. Nokia, 1,980. Make it 1,979 and talk about the person, the one person who came home one night and said: Honey, I lost my job. They called me in and they told me my job was gone. Well, was it because you weren't a good employee? No, I am a good employee. They just said we are moving the jobs to Mexico.
I have described other cases on the floor of the Senate of American workers who worked for careers and were making $11 an hour plus benefits. They all got fired in search of cheaper labor
by a company that moved their jobs. In that case, the jobs went to China. But the reason I told the story previously is that all of those workers who lost their jobs because they made $11 an hour--and that was way too much money--on the last day of work, as they pulled out of their driving spaces in the parking lot where their car used to park at a job they cared about, they all left a pair of empty shoes. It was a plaintive way for the employees of that company to send a message to the owners of that company who shipped their jobs overseas. It was a way of saying: You can move our jobs to China, but, by God, you are not going to fill our shoes. It was a message from the employees who cared about their jobs and cared about their work.
Well, Hufbauer/Schott and all the others who gave us those hifalutin estimates of new jobs with NAFTA, they said: By the way, there will be some jobs that will move south. But they will be low-skilled, low-wage jobs. But don't worry.
Well, guess what. The three largest imports to the United States today from Mexico are automobiles, automobile parts, and electronics, all the product of high-skilled jobs. Now, that is completely at odds with what was represented to the Congress and the American people.
I started this by saying the Wall Street Journal does a front-page feature story saying that Republicans don't believe free trade has been good for our country. They were doing a political story. But they needn't have said Republicans. Actually, the American people don't believe the so-called free trade agreements have been good for our country. Why is that? Because they are the ones who know. They are the ones who know, not the economists, not the folks who put on three-piece blue suits and suspenders every day and puff about what is going on in the world. It is the people who are working who lose their jobs and are facing downward pressure on income from these kinds of trade agreements.
Now, I am not suggesting, and would not ever suggest, that we shouldn't trade. I believe we ought to trade. I believe trade is important, and plenty of it. I just insist that it be fair. Whether it is Mexico, or China--the bilateral agreement with China--or South Korea or any number of trade agreements, I can point to the examples of what has happened that undermines the support of the American people for these agreements. Let me give you a couple.
South Korea. There is an agreement coming to the Senate Chamber dealing with South Korea. We have done other trade agreements with South Korea, and they have never met the commitments they made in those agreements, but nonetheless, an agreement with South Korea. Well, South Korea last year sent us roughly 700,000 automobiles. They put them on ships, sailed them across the ocean, and they offloaded them onto American docks and put them for sale in this country. We were able to sell about 5,000 vehicles in South Korea.
So 700,000 one way, 5,000 the other way. Why? Is that consumer preference? It is because in Korea 99 percent of the cars on Korean roads are made in Korea, and that is the way they want it. They do not want American cars sold in Korea. They have all kinds of devices to keep them out. We open our market. One-way trade. The American people understand that, and they do not support that.
I am going to mention one other thing. I have mentioned the bilateral agreement with China, with whom we have a giant trade deficit--$230 billion a year trade deficit. Not many people know that in the latest bilateral agreement with China--a country that is ramping up a very significant powerful automobile export industry. You will see Chinese cars on the streets in this country soon. They are aggressively ramping up an automobile export industry. Here is what our country decided to do with a country with which we have a very large deficit. We said to China: When you export your cars to the United States, we will impose a 2.5 percent tariff on cars you sell here, and it is okay for you, on any American cars we sell in China, to impose a tariff 10 times higher, at 25 percent. That is what we said to China.
That is unbelievably ignorant of our own economic interests. Is it surprising the Wall Street Journal does a poll that says the American people don't believe in this nonsense? They are living it. They lose their jobs. There is not one person in the Congress who has lost his or her job due to a bad trade agreement. It is the other folks out there who go to work in the morning and care about their job, who are doing the best they can and are told, by the way, you have to compete with Monterrey, or Chihuahua, or someone in Shenzhen, or Beijing who is willing to work for 30 cents an hour. And if you can't compete with them, we are sorry.
The result has been downward pressure on wages, fewer benefits, and problems for American workers. That is a very long description of why I wanted to offer an amendment. Finally, at long last, I wish to see a real evaluation done of what has been the net result of NAFTA, because we still have these folks running around here saying NAFTA has been a great success. I mean, I don't know if they are on their feet when they look at something and say it is successful or not, but you cannot take a sober look at this and say it is successful. Exports have grown, yes, but imports have grown much faster. The evidence is here. We have roughly 412,000 jobs that have been certified as having been lost to Mexico, certified by the Department of Labor as having been lost, because of the trade agreement--or at least been lost from the time the trade agreement was negotiated.
What I have asked for is a study, a real study to determine the number and types of jobs lost due to NAFTA and the number and types of jobs created due to NAFTA.
One final point. This administration has no problem figuring out how great trade deals will be for other countries. In fact, Wendy Cutler, Assistant U.S. Trade Representative, was touting the benefits that our trade agreement with Korea would offer to Korea. Let me quote her:
An FTA with the United States is predicted to produce
economic benefits for the Korean economy, increasing Korea's
real GDP by as much as 2 percent, establishing a foundation
to achieve per capita income to as high as $30,000, boosting
exports to the United States by 15 percent, and creating
100,000 new jobs.
That is what the USTR is saying, here is the nirvana that is going to exist if we can simply do this trade agreement: Here is what is going to exist for Korea.
Ask them, what will exist for our country? What will be the consequences for our country? What are the comparable numbers for the United States? They make no similar projection.
In fact, the Korean agreement comes to us now, not having addressed the issue of the imbalance in the bilateral automobile trade with Korea.
Anyway, it is a case where I hope, perhaps, repetition will someday breed success. It is a case where I believe we should trade. I believe our country should be a leader in trade. I believe our leadership ought to say we aspire to lift others up in the world, not push our workers down. We spent 100 years creating standards--safe workplace, child labor law, minimum wage, a whole series of standards that we ought to be proud of.
I believe in our trade agreements we ought to aspire to lift others up rather than push ourselves down, push our standards down. That has regrettably not been the case with NAFTA. It has not been the case with a number of other trade agreements and will likely not be the case with the next four agreements that will be brought to the Senate.
My colleagues and I, several of us, will be proposing establishing benchmarks and accountability at long last attached to trade agreements. We ought to have benchmarks and some accountability attached to those benchmarks to find out what has happened. You can't go on forever with a bad trade agreement. You can't go on forever with one that doesn't work. When we are awash in debt, as we are, over $700 billion a year in trade deficit--which inevitably will be repaid with a lower standard of living in the United States--then we are headed for trouble. We need a better trade strategy, one that encourages trade but one that demands and insists on fair trade for our own economic interests.
I yield the floor.
The town of Bryan, OH, was enormously proud of its product. It was the product that defined Bryan, OH. It was Etch A Sketch; every little kid played with Etch A Sketch. The folks in Bryan, OH, made Etch A Sketch and every kid played with them. Etch A Sketch is gone. They couldn't compete with China. And the Radio Flyer Little Red Wagon was made in Chicago for 110 years. It was made by an immigrant who started the company. Why was it called Radio Flyer, the Little Red Wagon? This immigrant was fascinated with two things. He liked Marconi, so he named it Radio, and he loved airplanes. So he decided to name it, the Little Red Wagon he crafted in Chicago, IL, as Radio Flyer, and virtually every kid in this country has ridden on Radio Flyer wagons.
They were here for 110 years but no more. Now they are made in China. We could go on at some length. Some people will say: Don't you understand, you two, the world has changed, for God's sake, the world has changed and they are going to make these things where you can pay 20 or 30 cents an hour.
My question to them is this: If that is where the jobs are, who is going to buy the products? In this country, it seems we built standards for a century to provide good wages and working conditions for the American worker and that is what provided the income and development and expansion of the middle class and gave them the earning power to buy products. I know the Senator agrees with me. He agrees with trade.
We come from agricultural States. We need to find a foreign market for what we produce, but trade has to be fair.